OxyContin Abuse-Deterrent Postmarketing Data Are In. Now What?

Road concept - next step
FDA to decide how to convey results of reformulated OxyContin postmarketing studies • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers